Leucine-rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre-synaptic sites.


Journal

Journal of neurochemistry
ISSN: 1471-4159
Titre abrégé: J Neurochem
Pays: England
ID NLM: 2985190R

Informations de publication

Date de publication:
08 2019
Historique:
received: 24 09 2018
revised: 20 05 2019
accepted: 28 05 2019
pubmed: 31 5 2019
medline: 19 3 2020
entrez: 1 6 2019
Statut: ppublish

Résumé

Leucine-rich repeat kinase 2 (LRRK2) is a large multidomain scaffolding protein with kinase and GTPase activities involved in synaptic vesicle (SV) dynamics. While its role in Parkinson's disease has been largely investigated, little is known about LRRK2 physiological role and until now few proteins have been described as substrates. We have previously demonstrated that LRRK2 through its WD40 domain interacts with synapsin I, an important SV-associated phosphoprotein involved in neuronal development and in the regulation of neurotransmitter release. To test whether synapsin I is substrate for LRRK2 and characterize the properties of its phosphorylation, we used in vitro kinase and binding assays as well as cellular model and site-direct mutagenesis. Using synaptosomes in superfusion, patch-clamp recordings in autaptic WT and synapsin I KO cortical neurons and SypHy assay on primary cortical culture from wild-type and BAC human LRRK2 G2019S mice we characterized the role of LRRK2 kinase activity on glutamate release and SV trafficking. Here we reported that synapsin I is phosphorylated by LRRK2 and demonstrated that the interaction between LRRK2 WD40 domain and synapsin I is crucial for this phosphorylation. Moreover, we showed that LRRK2 phosphorylation of synapsin I at threonine 337 and 339 significantly reduces synapsin I-SV/actin interactions. Using complementary experimental approaches, we demonstrated that LRRK2 controls glutamate release and SV dynamics in a kinase activity and synapsin I-dependent manner. Our findings show that synapsin I is a LRRK2 substrate and describe a novel mechanisms of regulation of glutamate release by LRRK2 kinase activity.

Identifiants

pubmed: 31148170
doi: 10.1111/jnc.14778
doi:

Substances chimiques

Synapsins 0
Glutamic Acid 3KX376GY7L
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

264-281

Informations de copyright

© 2019 International Society for Neurochemistry.

Auteurs

Antonella Marte (A)

Department of Experimental Medicine, University of Genova, Genova, Italy.

Isabella Russo (I)

Department of Biology, University of Padova, Padova, Italy.

Claudia Rebosio (C)

Department of Pharmacy, University of Genova, Genova, Italy.

Pierluigi Valente (P)

Department of Experimental Medicine, University of Genova, Genova, Italy.
IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Elisa Belluzzi (E)

Rheumatology Unit, Department of Medicine-DIMED, University Hospital of Padova, Padova, Italy.

Francesca Pischedda (F)

Center for Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Dulbecco Telethon Institute, Trento, Italy.

Caterina Montani (C)

Center for Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Dulbecco Telethon Institute, Trento, Italy.

Chiara Lavarello (C)

Laboratory of Mass Spectrometry - Core Facilities, Istituto Giannina Gaslini, Genova, Italy.

Andrea Petretto (A)

Laboratory of Mass Spectrometry - Core Facilities, Istituto Giannina Gaslini, Genova, Italy.

Ernesto Fedele (E)

Department of Pharmacy, University of Genova, Genova, Italy.
IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Pietro Baldelli (P)

Department of Experimental Medicine, University of Genova, Genova, Italy.
IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Fabio Benfenati (F)

IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy.

Giovanni Piccoli (G)

Center for Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Dulbecco Telethon Institute, Trento, Italy.

Elisa Greggio (E)

Department of Biology, University of Padova, Padova, Italy.

Franco Onofri (F)

Department of Experimental Medicine, University of Genova, Genova, Italy.
IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH